he company said in a statement that the recall was made only because of printing error and not due to any quality issue. The vaccine is a Combopack of (Comvac 3 BioHib) with two distinct component vaccine batches.
After a swift investigation, the company also informed the state drug authorities, center drug authorities and its CFA, marketing agents, vaccine administrators and doctors.
The company emphasised that there is no quality issue and the recall was purely because of printing error.